company-logo

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.

Corline Biomedical Dividend Announcement

Corline Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Corline Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Corline Biomedical Dividend History

Corline Biomedical Dividend Yield

Corline Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Corline Biomedical stock? Use our calculator to estimate your expected dividend yield:

Corline Biomedical Financial Ratios

P/E ratio-13.97
PEG ratio6.28
P/B ratio1.59
ROE-10.79%
Payout ratio0.00%
Current ratio1.14
Quick ratio1.14
Cash Ratio0.86

Corline Biomedical Dividend FAQ

Does Corline Biomedical stock pay dividends?
Corline Biomedical does not currently pay dividends to its shareholders.
Has Corline Biomedical ever paid a dividend?
No, Corline Biomedical has no a history of paying dividends to its shareholders. Corline Biomedical is not known for its dividend payments.
Why doesn't Corline Biomedical pay dividends?
There are several potential reasons why Corline Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Corline Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Corline Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Corline Biomedical a dividend aristocrat?
Corline Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Corline Biomedical a dividend king?
Corline Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Corline Biomedical a dividend stock?
No, Corline Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Corline Biomedical stocks?
To buy Corline Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Corline Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.